Table 5.
The ROC Analysis for MULTIPLATE®
| Group A vs. Group B |
Survivors vs. Group A |
Survivors vs. Group B |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| AUC | 95% CI | P value | AUC | 95% CI | P value | AUC | 95% CI | P value | |
| ADP-test | 0.83 | 0.65–0.97 | 0.006 | 0.83 | 0.65–0.99 | 0.003 | 0.51 | 0.31–0.71 | 0.960 |
| ASPI-test | 0.85 | 0.68–0.99 | 0.003 | 0.79 | 0.64–0.95 | 0.005 | 0.50 | 0.26–0.74 | 1.000 |
| TRAP-test | 0.88 | 0.75–0.95 | 0.001 | 0.83 | 0.68–0.99 | 0.002 | 0.53 | 0.32–0.73 | 0.820 |
Group A: non-survivors at 28 days, Group B: non-survivors between days 29 and 90 after enrollment. ROC: receiver operating characteristic, ADP: adenosine diphosphate test, ASPI: arachidonic acid test; TRAP: thrombin receptor activating peptide-6 test.